文献速递艾滋病与性传播感染

母亲HIV耐药与垂直传播相关且在感染婴儿中流行

Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants.
PubMed 文献 · Clin Infect Dis · 2022-01-01

该病例对照研究基于PROMISE研究参与者,纳入85例垂直传播病例和255例匹配对照,分析母亲HIV耐药与传播风险及婴儿耐药动态。母亲耐药与宫内/围产期传播无关,但母亲病毒载量和耐药是母乳喂养期间传播的独立危险因素,且耐药在感染婴儿中被选择。提示单用奈韦拉平可能不足以预防母乳中的耐药变异。

要点

  • 母亲HIV耐药和病毒载量是母乳喂养期间垂直传播的独立危险因素。
  • 母亲耐药与宫内/围产期传播无显著关联。
  • 感染婴儿中存在HIV耐药选择,单用奈韦拉平预防可能不足。

核心结论

  • 母亲HIV耐药和病毒载量是母乳喂养期间垂直传播的独立危险因素。
  • 单用奈韦拉平可能不足以作为婴儿预防耐药变异(来自母乳)的方案。

研究设计与样本

  • PROMISE研究的病例对照研究,病例为垂直传播的母婴对,对照为未传播的母婴对,按分娩日期和临床中心1:3匹配。
  • 共纳入85例病例和255例匹配对照,对母亲和婴儿血浆进行基因型HIV耐药分析。

主要发现

  • 调整血浆HIV RNA载量、入组CD4计数和产前方案后,母亲HIV耐药与宫内/围产期传播无关。
  • 母亲血浆HIV RNA载量和HIV耐药均为母乳喂养期间垂直传播的独立危险因素。
  • 在感染婴儿的婴儿期内观察到HIV耐药被选择。

临床怎么用

  • 应努力在孕期实现HIV复制抑制。
  • 母乳喂养婴儿的预防方案可能需要比单用奈韦拉平更高的耐药屏障。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to assess if maternal human immunodeficiency virus (HIV) drug resistance is associated with an increased risk of HIV vertical transmission and to describe the dynamics of drug resistance in HIV-infected infants. METHODS: This was a case-control study of PROMISE study participants. "Cases" were mother-infant pairs with HIV vertical transmission during pregnancy or breastfeeding and "controls" were mother-infant pairs without transmission matched 1:3 by delivery date and clinical site. Genotypic HIV drug resistance analyses were performed on mothers' and their infants' plasma at or near the time of infant HIV diagnosis. Longitudinal analysis of genotypic resistance was assessed in available specimens from infants, from diagnosis and beyond, including antiretroviral therapy (ART) initiation and last study visits. RESULTS: Our analyses included 85 cases and 255 matched controls. Maternal HIV drug resistance, adjusted for plasma HIV RNA load at infant HIV diagnosis, enrollment CD4 count, and antepartum regimens, was not associated with in utero/peripartum HIV transmission. In contrast, both maternal plasma HIV RNA load and HIV drug resistance were independent risk factors associated with vertical transmission during breastfeeding. Furthermore, HIV drug resistance was selected across infected infants during infancy. CONCLUSIONS: Maternal HIV drug resistance and maternal viral load were independent risk factors for vertical transmission during breastfeeding, suggesting that nevirapine alone may be insufficient infant prophylaxis against drug-resistant variants in maternal breast milk. These findings support efforts to achieve suppression of HIV replication during pregnancy and suggest that breastfeeding infants may benefit from prophylaxis with a greater barrier to drug resistance than nevirapine alone.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Boyce CL, Sils T, Ko D, et al. Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants. Clin Infect Dis. 2022. PMID: 34467974. doi:10.1093/cid/ciab744

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。